ES2189213T3 - Utilizacion de un compuesto de tipo retinoide para aumentar in vivo la actividad de desacoplamiento de la proteina ucp2. - Google Patents
Utilizacion de un compuesto de tipo retinoide para aumentar in vivo la actividad de desacoplamiento de la proteina ucp2.Info
- Publication number
- ES2189213T3 ES2189213T3 ES98936435T ES98936435T ES2189213T3 ES 2189213 T3 ES2189213 T3 ES 2189213T3 ES 98936435 T ES98936435 T ES 98936435T ES 98936435 T ES98936435 T ES 98936435T ES 2189213 T3 ES2189213 T3 ES 2189213T3
- Authority
- ES
- Spain
- Prior art keywords
- activity
- vivo
- increase
- decooplation
- type compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000008219 Uncoupling Protein 2 Human genes 0.000 title abstract 2
- 108010021111 Uncoupling Protein 2 Proteins 0.000 title abstract 2
- 150000004492 retinoid derivatives Chemical class 0.000 title abstract 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229930002330 retinoic acid Natural products 0.000 abstract 2
- 229960001727 tretinoin Drugs 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Utilización de un compuesto de tipo retinoide para la preparación de un medicamento capaz de aumentar la actividad desacopladora de las proteínas UCP2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9710009A FR2767058B1 (fr) | 1997-08-05 | 1997-08-05 | Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2189213T3 true ES2189213T3 (es) | 2003-07-01 |
Family
ID=9510039
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009801680A Expired - Fee Related ES2147519B1 (es) | 1997-08-05 | 1998-08-05 | Utilizacion de un compuesto de tipo retinoide para modular in vivo la actividad desacopladora de la proteina ucp2. |
ES98936435T Expired - Lifetime ES2189213T3 (es) | 1997-08-05 | 1998-08-05 | Utilizacion de un compuesto de tipo retinoide para aumentar in vivo la actividad de desacoplamiento de la proteina ucp2. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009801680A Expired - Fee Related ES2147519B1 (es) | 1997-08-05 | 1998-08-05 | Utilizacion de un compuesto de tipo retinoide para modular in vivo la actividad desacopladora de la proteina ucp2. |
Country Status (9)
Country | Link |
---|---|
US (2) | US20030229143A1 (es) |
EP (1) | EP1018338B1 (es) |
AT (1) | ATE228362T1 (es) |
AU (1) | AU8543098A (es) |
CA (1) | CA2299270A1 (es) |
DE (1) | DE69809785T2 (es) |
ES (2) | ES2147519B1 (es) |
FR (1) | FR2767058B1 (es) |
WO (1) | WO1999007358A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6576906B1 (en) | 1999-10-08 | 2003-06-10 | Symyx Technologies, Inc. | Method and apparatus for screening combinatorial libraries for semiconducting properties |
WO2001035096A2 (en) * | 1999-11-10 | 2001-05-17 | Mitokor | Diseases associated with altered mitochondrial function |
US6365796B1 (en) | 2000-02-16 | 2002-04-02 | Beth Israel Deaconess Medical Center | Transgenic UCP2 knockout mouse and use thereof |
WO2001075131A2 (en) * | 2000-03-31 | 2001-10-11 | University Technology Corporation | Expression of uncoupling protein (ucp) in plants |
US7105718B2 (en) | 2000-03-31 | 2006-09-12 | The Regents Of The University Of Colorado | Compositions and methods for regulating metabolism in plants |
ES2177404B1 (es) * | 2000-07-07 | 2004-09-16 | Consejo Superior De Investigaciones Cientificas | Procedimiento para la determinacion de la actividad de las proteinas desacoplantes (ucps) mediante la monitorizacion del consumo de nad (p) h. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5051449A (en) * | 1991-02-27 | 1991-09-24 | Kligman Albert M | Treatment of cellulite with retinoids |
US5219888A (en) * | 1992-03-31 | 1993-06-15 | American Cyanamid Company | Use of retinoids for the treatment of coronary artery disease |
TW272187B (es) * | 1992-05-20 | 1996-03-11 | Hoffmann La Roche | |
US5457129A (en) * | 1993-05-17 | 1995-10-10 | Research Development Foundation | Inhibition of nitric oxide production by retinoic acid |
WO1995018533A1 (en) * | 1994-01-04 | 1995-07-13 | The Trustees Of The University Of Pennsylvania | Methods and compounds affecting adipocyte differentiation and obesity |
FR2723315B1 (fr) * | 1994-08-02 | 1996-10-25 | Cird Galderma | Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes |
US5489611A (en) * | 1995-02-10 | 1996-02-06 | Warner-Lambert Company | Method for lowering plasma levels of lipoprotein (a) |
FR2735367B1 (fr) * | 1995-06-19 | 1997-07-18 | Cird Galderma | Utilisation de ligands specifiques des recepteurs rxrs |
KR19990045756A (ko) * | 1995-09-18 | 1999-06-25 | 윌리암 엘. 레스페스 | Rxr 작용제를 이용하는 niddm 치료 방법 |
-
1997
- 1997-08-05 FR FR9710009A patent/FR2767058B1/fr not_active Expired - Fee Related
-
1998
- 1998-08-05 WO PCT/ES1998/000225 patent/WO1999007358A1/es active IP Right Grant
- 1998-08-05 ES ES009801680A patent/ES2147519B1/es not_active Expired - Fee Related
- 1998-08-05 ES ES98936435T patent/ES2189213T3/es not_active Expired - Lifetime
- 1998-08-05 AT AT98936435T patent/ATE228362T1/de not_active IP Right Cessation
- 1998-08-05 DE DE69809785T patent/DE69809785T2/de not_active Expired - Fee Related
- 1998-08-05 EP EP98936435A patent/EP1018338B1/en not_active Expired - Lifetime
- 1998-08-05 AU AU85430/98A patent/AU8543098A/en not_active Abandoned
- 1998-08-05 CA CA002299270A patent/CA2299270A1/en not_active Abandoned
-
2003
- 2003-01-16 US US10/345,835 patent/US20030229143A1/en not_active Abandoned
-
2006
- 2006-03-20 US US11/385,032 patent/US20070015830A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030229143A1 (en) | 2003-12-11 |
FR2767058A1 (fr) | 1999-02-12 |
DE69809785T2 (de) | 2003-09-18 |
US20070015830A1 (en) | 2007-01-18 |
WO1999007358A1 (es) | 1999-02-18 |
EP1018338B1 (en) | 2002-11-27 |
ES2147519A1 (es) | 2000-09-01 |
AU8543098A (en) | 1999-03-01 |
CA2299270A1 (en) | 1999-02-18 |
FR2767058B1 (fr) | 2000-05-05 |
EP1018338A1 (en) | 2000-07-12 |
DE69809785D1 (de) | 2003-01-09 |
ES2147519B1 (es) | 2001-03-16 |
ATE228362T1 (de) | 2002-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9808348A (pt) | Alimento medicinal para diabéticos | |
BR9816013A (pt) | Proteìna de ligação de interleucina-18 | |
DK0509317T3 (da) | Lægemidler imod knoglesygdomme | |
DE59009175D1 (de) | Endoskop für die nasale Chirurgie. | |
BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
HUP9700603A1 (hu) | Gyógyászati készítmény véralvadási zavarok kezelésére | |
PT730864E (pt) | Medicamento para tratar doencas inflamatorias cardiacas | |
ATE262336T1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
BR9714200A (pt) | Análogos de hormÈnio paratiróide | |
ATE466106T1 (de) | Zusammensetzungen für die diagnose und therapie von erkrankungen, die im zusammenhang mit einer anomalen expression von futrinen (r-spondinen) stehen | |
LU93259I2 (fr) | LETIFEND (Protein Q) | |
ATE493978T1 (de) | Behandlung von autoimmunerkrankungen | |
EA199700380A1 (ru) | Бициклические ароматические соединения, фармацевтическая и косметическая композиции на их основе и применение косметической композиции | |
PT87523A (pt) | Mischkristalle aus insulin und insulinderivaten verfahren zur herstellung dieser mischkristalle diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus | |
ES2189213T3 (es) | Utilizacion de un compuesto de tipo retinoide para aumentar in vivo la actividad de desacoplamiento de la proteina ucp2. | |
BR9913337A (pt) | Derivados tan-1057 | |
BR9804921A (pt) | Peptìdeo natriurético atrial (anp) como um aditivo para soluções de diálise peritoneal. | |
DE60107888D1 (de) | Beta-Interferon zur Behandlung von Immunerkrankungen | |
DK0588477T3 (da) | Medicinsk præparat omfatende TCF-11 | |
EA199901061A1 (ru) | Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии | |
ATE317021T1 (de) | Antisense modulierung von lfa-3 | |
IT1290828B1 (it) | Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche | |
PT869785E (pt) | 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente | |
DE69000791D1 (de) | Therapeutische mittel fuer metabolische knochenkrankheiten. | |
PT878195E (pt) | Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio |